share_log

Veeva Systems | 8-K: Veeva Announces Fiscal 2025 First Quarter Results

SEC ·  May 31, 2024 04:19

Summary by Moomoo AI

On May 30, 2024, Veeva Systems Inc., a leading cloud solutions provider for the global life sciences industry, reported its financial results for the first quarter ended April 30, 2024. The company announced a 24% year-over-year increase in total revenues, reaching $650.3 million, with subscription services revenues growing by 29% to $534.0 million. Operating income saw a significant rise of 152% to $155.2 million, while non-GAAP operating income increased by 66% to $260.9 million. Net income also grew by 23% to $161.7 million, and non-GAAP net income surged by 67% to $247.0 million. Earnings per share were reported at $0.98, up from $0.81 in the previous year, and non-GAAP earnings per share increased to $1.50 from $0.91. Veeva's interim CFO Tim Cabral highlighted the company's better-than-expected performance across all metrics and...Show More
On May 30, 2024, Veeva Systems Inc., a leading cloud solutions provider for the global life sciences industry, reported its financial results for the first quarter ended April 30, 2024. The company announced a 24% year-over-year increase in total revenues, reaching $650.3 million, with subscription services revenues growing by 29% to $534.0 million. Operating income saw a significant rise of 152% to $155.2 million, while non-GAAP operating income increased by 66% to $260.9 million. Net income also grew by 23% to $161.7 million, and non-GAAP net income surged by 67% to $247.0 million. Earnings per share were reported at $0.98, up from $0.81 in the previous year, and non-GAAP earnings per share increased to $1.50 from $0.91. Veeva's interim CFO Tim Cabral highlighted the company's better-than-expected performance across all metrics and expressed confidence in Veeva's growth trajectory and commitment to customer success. The company also provided guidance for the second quarter with total revenues expected between $666 and $669 million, and for the fiscal year ending January 31, 2025, with revenues projected between $2,700 and $2,710 million. The report included recent business highlights, such as the selection of Veeva Development Cloud applications by three top 20 biopharmaceutical companies and the full availability of Vault CRM for new customers.

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Related Stocks Related Stocks
    Symbol Mini Chart Price
    Forian
    FORA
    -- 3.590
    Ontrak
    OTRK
    -- 1.5900
    Mangoceuticals
    MGRX
    -- 4.840
    DarioHealth
    DRIO
    -- 0.700
    VSee Health
    VSEE
    -- 1.870
    Log In for the Full List
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
    Discussing
    Big Tech’s earnings season in full swing! Nvidia is the only one left
    On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
    AMZN earnings preview: Grab rewards by guessing the opening price!